Analytical Data
-
基因名
PLGF
- Application
-
别名
PlGF2; PGF; PGFL; Placental Growth Factor-Like; Vascular Endothelial Growth Factor-Related Protein
-
种属
Mouse
-
表达系统
E. coli
-
标签
N- His & GST
-
纯度
Greater than 95% as determined by SDS-PAGE.
-
蛋白编号
P49764
-
表达区间
Val19~Pro158
-
蛋白长度
Partial
-
分子量
46/38kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Human GDF-8 Protein(CHO)
Cat：IPD-X11629
Recombinant Human PLGF Protein, N-His
Cat：IPD-X13037
Protein Description
The research on Placentally-derived Growth Factor (PLGF) recombinant protein has garnered significant attention due to its vital role in angiogenesis and vascular biology. PLGF, a member of the vascular endothelial growth factor (VEGF) family, is primarily expressed in placental tissues and plays a critical role in the development of the placenta and embryonic growth. Its ability to regulate blood vessel formation makes it a focal point in studies related to various pathological conditions, including cancer, cardiovascular diseases, and wound healing. Recent findings suggest that PLGF influences not only endothelial cell functions but also the recruitment and activation of immune cells, positioning it as a potential therapeutic target for enhancing tissue regeneration and modulating immune responses. Researchers are exploring recombinant PLGF for clinical applications, leveraging its properties to develop novel therapies aimed at improving outcomes in diseases characterized by inadequate angiogenesis or excessive vascular growth. As the understanding of PLGF's molecular mechanisms deepens, there is a growing interest in its potential to serve as a biomarker for pregnancy-related complications and its suitability for therapeutic interventions in various diseases, highlighting the importance of continued research in this field.
